ABUS compared with TDAY: revenue, margins and what each company keeps, and the suppliers and customers both name

ABUSArbutus Biopharma Corp

Mkt capRevenueRevenue

TDAYUSA TODAY Co., Inc.

Mkt capRevenueRevenue

Compare

ABUSArbutus Biopharma Corp

TDAYUSA TODAY Co., Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

ABUS

0 of 3at or beyond implied

Reportimpliedrealized× implied

Q2 FY26—▼−1.71%—

May 13 '26±6.5%0.00%×0.00

Q1 FY26±13.7%▲+4.25%×0.31

Q3 FY25±22.5%▼−5.79%×0.26

TDAY

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±13.0%▲+0.82%×0.06

Q2 FY26±8.6%▼−7.62%×0.88

= impliedABUS realized, solidTDAY realized, hatchedOne scale, both sides: full bar = 23%× = |realized| ÷ impliedSource: market data

Q1 FY26

±12.2%

▼−0.69%

×0.06

Feb 26 '26±14.3%▲+4.58%×0.32

ABUSArbutus Biopharma Corp

3.66▼−0.41%· post 3.66

Mkt cap$723.1MRevenue$1MQ2 FY26Revenue$14MFY25

TDAYUSA TODAY Co., Inc.

6.57▲+7.27%· post 6.57

ClosedNov 6 '26

Mkt cap$971.3MRevenue$519MQ3 FY26Revenue$2.3BFY25

Compare

ClosedNov 6 '26

ABUSArbutus Biopharma Corp

TDAYUSA TODAY Co., Inc.

3.66▼−0.41%post 3.66

Price

6.57▲+7.27%post 6.57

$723.1M

Mkt cap

$971.3M

Q2 FY26$1M

Revenue

$519MQ3 FY26

FY25$14M

Revenue

$2.3BFY25

ABUS3.66▼−0.41%vsTDAY6.57▲+7.27%ClosedNov 6 '26